OncoZenge AB's market cap is currently kr82.84M. The company's EPS TTM is kr-0.202; its P/E ratio is -10.32; OncoZenge AB is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
